Published in Contact Dermatitis on June 01, 2006
Efficacy and Tolerance Evaluation of a Topical "Revitalizing" Face Day Cream | NCT02230397
Increased skin barrier disruption by sodium lauryl sulfate in mice expressing a constitutively active STAT6 in T cells. Arch Dermatol Res (2011) 0.84
Absorption of chemicals through compromised skin. Int Arch Occup Environ Health (2009) 0.77
Human and Environmental Toxicity of Sodium Lauryl Sulfate (SLS): Evidence for Safe Use in Household Cleaning Products. Environ Health Insights (2015) 0.75
Sensitive Skin: Assessment of the Skin Barrier Using Confocal Raman Microspectroscopy. Skin Pharmacol Physiol (2017) 0.75
Analysis of Serum Cytokine Profile in Pemphigus. Ann Dermatol (2017) 0.75
Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect. J Invest Dermatol (2011) 1.97
Role of marker lesion when applying intravesical instillations of IL-2 for non-muscle-invasive bladder cancer comparison of the therapeutic effects in two pilot studies. Anticancer Res (2013) 1.93
Caspase-14 is required for filaggrin degradation to natural moisturizing factors in the skin. J Invest Dermatol (2011) 1.93
Increased sensitivity of histidinemic mice to UVB radiation suggests a crucial role of endogenous urocanic acid in photoprotection. J Invest Dermatol (2010) 1.78
Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol (2008) 1.67
Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients. J Invest Dermatol (2006) 1.62
Knockdown of filaggrin impairs diffusion barrier function and increases UV sensitivity in a human skin model. J Invest Dermatol (2010) 1.59
Contact allergy to capryloyl salicylic acid. Contact Dermatitis (2014) 1.39
Dendritic cells: biology of the skin. Contact Dermatitis (2009) 1.11
Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients. J Lipid Res (2012) 1.11
Increased CCL27-CCR10 expression in allergic contact dermatitis: implications for local skin memory. J Pathol (2004) 1.10
Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss-of-function mutations. J Invest Dermatol (2010) 1.04
Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes. Wound Repair Regen (2007) 1.03
Hand eczema severity and quality of life: a cross-sectional, multicentre study of hand eczema patients. Contact Dermatitis (2008) 1.00
Up-regulation of drug resistance-related vaults during dendritic cell development. J Immunol (2002) 0.96
Cytokines at different stratum corneum levels in normal and sodium lauryl sulphate-irritated skin. Skin Res Technol (2007) 0.93
Local therapy of cancer with free IL-2. Cancer Immunol Immunother (2008) 0.93
Lamellar lipid organization and ceramide composition in the stratum corneum of patients with atopic eczema. J Invest Dermatol (2011) 0.93
Cytokine gene polymorphisms and susceptibility to chronic irritant contact dermatitis. Contact Dermatitis (2008) 0.92
Current patch test results with the European baseline series and extensions to it from the 'European Surveillance System on Contact Allergy' network, 2007-2008. Contact Dermatitis (2012) 0.92
Multicentre patch testing with methylisothiazolinone by the European Environmental and Contact Dermatitis Research Group. Contact Dermatitis (2014) 0.91
Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin. Exp Dermatol (2012) 0.89
In vitro and in vivo protein delivery from in situ forming poly(ethylene glycol)-poly(lactide) hydrogels. J Control Release (2007) 0.88
Hands4U: a multifaceted strategy to implement guideline-based recommendations to prevent hand eczema in health care workers: design of a randomised controlled trial and (cost) effectiveness evaluation. BMC Public Health (2011) 0.88
Contact sensitisation in hand eczema patients-relation to subdiagnosis, severity and quality of life: a multi-centre study. Contact Dermatitis (2009) 0.87
The European baseline series in 10 European Countries, 2005/2006--results of the European Surveillance System on Contact Allergies (ESSCA). Contact Dermatitis (2009) 0.87
"First do no harm" and the importance of prediction in oncology. EPMA J (2010) 0.86
In situ crosslinked biodegradable hydrogels loaded with IL-2 are effective tools for local IL-2 therapy. Eur J Pharm Sci (2004) 0.86
Polymorphisms in the interleukin-1 gene influence the stratum corneum interleukin-1 alpha concentration in uninvolved skin of patients with chronic irritant contact dermatitis. Contact Dermatitis (2008) 0.84
Prediction of response in cancer immunotherapy. Anticancer Res (2011) 0.84
Prognostic significance of peripheral blood CD8highCD57+ lymphocytes in bladder carcinoma patients after intravesical IL-2. Anticancer Res (2011) 0.84
Anaphylactic reaction to different gonadotropin-releasing hormone agonists for the treatment of endometriosis. Am J Med Sci (2011) 0.84
Subtoxic concentrations of allergenic haptens induce LC migration and maturation in a human organotypic skin explant culture model: a novel method for identifying potential contact allergens. Exp Dermatol (2006) 0.83
Airborne irritant contact dermatitis due to synthetic fibres from an air-conditioning filter. Contact Dermatitis (2005) 0.83
Self-testing for contact sensitization to hair dyes--scientific considerations and clinical concerns of an industry-led screening programme. Contact Dermatitis (2012) 0.83
Wet work and hand eczema in apprentice nurses; part I of a prospective cohort study. Contact Dermatitis (2013) 0.82
Increased permeability for polyethylene glycols through skin compromised by sodium lauryl sulphate. Exp Dermatol (2006) 0.82
Comparison of wound closure after burn and cold injury in human skin equivalents. J Invest Dermatol (2006) 0.82
T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays. Cell Mol Life Sci (2010) 0.82
Sensitization to palladium in Europe. Contact Dermatitis (2014) 0.81
Impact of tumour necrosis factor-α polymorphisms on irritant contact dermatitis. Contact Dermatitis (2012) 0.81
Improved detection of allergen-specific T-cell responses in allergic contact dermatitis through the addition of 'cytokine cocktails'. Exp Dermatol (2005) 0.81
Sensitization to palladium and nickel in Europe and the relationship with oral disease and dental alloys. Contact Dermatitis (2015) 0.80
Individual susceptibility to occupational contact dermatitis. Ind Health (2009) 0.80
Skin barrier integrity and natural moisturising factor levels after cumulative dermal exposure to alkaline agents in atopic dermatitis. Acta Derm Venereol (2014) 0.80
Genetic polymorphism of metabolic enzymes modifies the risk of chronic solvent-induced encephalopathy. Toxicol Ind Health (2006) 0.80
Palladium-based dental alloys are associated with oral disease and palladium-induced immune responses. Contact Dermatitis (2014) 0.80
Economic evaluation of an integrated care programme for patients with hand dermatitis. Contact Dermatitis (2013) 0.79
Percutaneous absorption and metabolism of 2-butoxyethanol in human volunteers: a microdialysis study. Toxicol Lett (2007) 0.79
p-Phenylenediamine sensitization is more prevalent in central and southern European patch test centres than in Scandinavian: results from a multicentre study. Contact Dermatitis (2009) 0.79
Allergic contact dermatitis to nickel: modified in vitro test protocols for better detection of allergen-specific response. Contact Dermatitis (2007) 0.78
Differential cytokine expression in skin after single and repeated irritation by sodium lauryl sulphate. Exp Dermatol (2007) 0.78
Serum testosterone plays an important role in the metastatic ability of castration resistant prostate cancer. World J Urol (2012) 0.78
How to improve skin notation. Position paper from a workshop. Regul Toxicol Pharmacol (2007) 0.78
Barrier Function and Natural Moisturizing Factor Levels After Cumula-tive Exposure to Short-chain Aliphatic Alcohols and Detergents: Results of Occlusion-modified Tandem Repeated Irritation Test. Acta Derm Venereol (2016) 0.78
Photopatch testing: recommendations for a European photopatch test baseline series. Contact Dermatitis (2013) 0.78
The role of the skin irritation response in polysensitization to fragrances. Contact Dermatitis (2012) 0.78
The effectiveness of integrated care for patients with hand eczema: results of a randomized, controlled trial. Contact Dermatitis (2012) 0.78
Follow-up of the monitored levels of preservative sensitivity in Europe: overview of the years 2001-2008. Contact Dermatitis (2012) 0.78
Stratum Corneum Tape Stripping: Monitoring of Inflammatory Mediators in Atopic Dermatitis Patients Using Topical Therapy. Int Arch Allergy Immunol (2016) 0.77
Contact allergy to common ingredients in hair dyes. Contact Dermatitis (2013) 0.77
Changes in cytokine profile during local IL-2 therapy in cancer patients. Anticancer Res (2006) 0.77
Skin barrier dysfunction in non-lesional atopic eczema: the role of stratum corneum lipids. Eur J Dermatol (2013) 0.77
Sodium tetrachloropalladate for diagnosing palladium sensitization. Contact Dermatitis (2012) 0.77
Intratumoural interleukin-2 therapy can induce regression of non-resectable mastocytoma in dogs. Anticancer Res (2013) 0.76
A two-centre evaluation of the human organotypic skin explant culture model for screening contact allergens. Altern Lab Anim (2003) 0.76
Quantification of wet-work exposure in nurses using a newly developed wet-work exposure monitor. Ann Occup Hyg (2011) 0.76
Filaggrin loss-of-function mutations and atopic dermatitis as risk factors for hand eczema in apprentice nurses: part II of a prospective cohort study. Contact Dermatitis (2013) 0.76
Genotype-phenotype associations in filaggrin loss-of-function mutation carriers. Contact Dermatitis (2013) 0.76
The Amiens Strategy: small phase III trials for clinically relevant progress in the war against cancer. J Clin Oncol (2009) 0.76
Progress and future of in vitro models to study translocation of nanoparticles. Arch Toxicol (2015) 0.76
Revealing barriers and facilitators to use a new genetic test: comparison of three user involvement methods. J Community Genet (2012) 0.75
Intrinsic characteristics of contact and respiratory allergens influence production of polarizing cytokines by dendritic cells. Contact Dermatitis (2006) 0.75
Palladium allergy prevalence is underestimated because of an inadequate test allergen. Contact Dermatitis (2011) 0.75
Local interleukin-2 and interleukin-12 therapy of bovine ocular squamous cell carcinomas. Vet Immunol Immunopathol (2005) 0.75
Filaggrin and Skin Barrier Function. Curr Probl Dermatol (2016) 0.75
Analysis, interpretation, and extrapolation of dermal permeation data using diffusion-based mathematical models. J Pharm Sci (2007) 0.75
Do 'cinnamon-sensitive' patients react to cinnamate UV filters? Contact Dermatitis (2009) 0.75
The puzzled low prevalence of atopic dermatitis in kindergarten children in Romania. Pediatr Allergy Immunol (2013) 0.75
Expression of Filaggrin and its Degradation Products in Human Skin Following Erythemal Doses of Ultraviolet B Irradiation. Acta Derm Venereol (2017) 0.75
Sodium tetrachloropalladate (Na2[PdCl4]) as an improved test salt for palladium allergy patch testing. Contact Dermatitis (2008) 0.75
Anogenital allergic contact dermatitis, the role of spices and flavour allergy. Contact Dermatitis (2008) 0.75
Efficacy of a Cream Containing Ceramides and Magnesium in the Treatment of Mild to Moderate Atopic Dermatitis: A Randomized, Double-blind, Emollient- and Hydrocortisone-controlled Trial. Acta Derm Venereol (2016) 0.75
Occupational allergic contact dermatitis and Type I sensitization caused by Gerbera in a greenhouse worker. Contact Dermatitis (2002) 0.75